Novo Holdings A/S 13D and 13G filings for Lexeo Therapeutics, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-12-15 4:51 pm Purchase |
2023-12-11 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
Novo Holdings A/S | 1,307,829 4.900% |
13,776 (+1.06%) |
Filing |
| 2023-11-24 4:33 pm Purchase |
2023-11-15 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
Novo Holdings A/S | 1,294,053 5.100% |
1,294,053 (New Position) |
Filing |